Kamiya, Y., Ota, S., Tanaka, Y., Yamashita, K., Takaki, A., & Ito, S. (2018). Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease. Asia Oceania Journal of Nuclear Medicine & Biology, 6(2), 129. https://doi.org/10.22038/aojnmb.2018.10595
Chicago Style (17th ed.) CitationKamiya, Yoshito, Satoru Ota, Yuta Tanaka, Kosuke Yamashita, Akihiro Takaki, and Shigeki Ito. "Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease." Asia Oceania Journal of Nuclear Medicine & Biology 6, no. 2 (2018): 129. https://doi.org/10.22038/aojnmb.2018.10595.
MLA (9th ed.) CitationKamiya, Yoshito, et al. "Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease." Asia Oceania Journal of Nuclear Medicine & Biology, vol. 6, no. 2, 2018, p. 129, https://doi.org/10.22038/aojnmb.2018.10595.